ELV
Elevance Health, Inc.
NYSE: ELV · Indianapolis, IN · Healthcare
$439.95-5.33 (-1.20%)Closed
Market Cap$95.08B
Cash$10.35Bmost recent
Runwayprofitable
P/E (TTM)17.5EPS $25.21
52-Wk Range$276.68 – $445.28
Avg Volume1.6M3-month
Price & Trading Activity
Daily close with catalyst overlays and trading volume
$439.95+9.0%
Pipeline
Drug candidates sponsored by ELV · ClinicalTrials.gov
Couldn't load pipeline. ClinicalTrials.gov or the backend may be unavailable.
Valuation
Risk-adjusted NPV
Loading pipeline…
Peer comparison
Cohort check
No peer cohort defined for ELV. Cohorts currently cover gene editing, mRNA, rare-disease gene therapy, and large-cap biotech — more coming soon.